Literature DB >> 19800177

Accounting for chance in the calculus of autoimmune disease.

Daniel J Moore1.   

Abstract

Discussions around the etiology of autoimmune disease routinely focus on the interplay between genes and the environment. In turn, efforts to ameliorate these diseases seek to modify genetic and environmental factors. However, there may be a third element that also accounts for the progression of autoimmunity. This article explores the role of chance, exemplified by the stochastic process of immune repertoire generation, in the evolution of autoimmunity. The presented modeling studies and concepts suggest that chance plays as significant a role as genes or environment. This hypothesis implies that a full understanding of the role of genes and environment will also require investigators to account for stochastic processes in building comprehensive disease models.

Entities:  

Mesh:

Year:  2009        PMID: 19800177      PMCID: PMC2815044          DOI: 10.1016/j.mehy.2009.09.009

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  28 in total

1.  Comparison of the seasonal pattern in the clinical onset of IDDM in Finland and Sardinia.

Authors:  M Karvonen; V Jäntti; S Muntoni; M Stabilini; L Stabilini; S Muntoni; J Tuomilehto
Journal:  Diabetes Care       Date:  1998-07       Impact factor: 19.112

Review 2.  Putative environmental factors in Type 1 diabetes.

Authors:  H K Akerblom; M Knip
Journal:  Diabetes Metab Rev       Date:  1998-03

3.  I-Ag7-mediated antigen presentation by B lymphocytes is critical in overcoming a checkpoint in T cell tolerance to islet beta cells of nonobese diabetic mice.

Authors:  H Noorchashm; Y K Lieu; N Noorchashm; S Y Rostami; S A Greeley; A Schlachterman; H K Song; L E Noto; A M Jevnikar; C F Barker; A Naji
Journal:  J Immunol       Date:  1999-07-15       Impact factor: 5.422

4.  Development of insulitis and diabetes in B cell-deficient NOD mice.

Authors:  M Yang; B Charlton; A M Gautam
Journal:  J Autoimmun       Date:  1997-06       Impact factor: 7.094

5.  CD4+ and CD8+ T-cell clones from congenital rubella syndrome patients with IDDM recognize overlapping GAD65 protein epitopes. Implications for HLA class I and II allelic linkage to disease susceptibility.

Authors:  D Ou; L A Jonsen; D L Metzger; A J Tingle
Journal:  Hum Immunol       Date:  1999-08       Impact factor: 2.850

6.  Genetic determination of islet cell autoimmunity in monozygotic twin, dizygotic twin, and non-twin siblings of patients with type 1 diabetes: prospective twin study.

Authors:  M J Redondo; M Rewers; L Yu; S Garg; C C Pilcher; R B Elliott; G S Eisenbarth
Journal:  BMJ       Date:  1999-03-13

7.  Number of autoantibodies (against insulin, GAD or ICA512/IA2) rather than particular autoantibody specificities determines risk of type I diabetes.

Authors:  C F Verge; R Gianani; E Kawasaki; L Yu; M Pietropaolo; H P Chase; G S Eisenbarth
Journal:  J Autoimmun       Date:  1996-06       Impact factor: 7.094

8.  Large-scale genetic fine mapping and genotype-phenotype associations implicate polymorphism in the IL2RA region in type 1 diabetes.

Authors:  Christopher E Lowe; Jason D Cooper; Todd Brusko; Neil M Walker; Deborah J Smyth; Rebecca Bailey; Kirsi Bourget; Vincent Plagnol; Sarah Field; Mark Atkinson; David G Clayton; Linda S Wicker; John A Todd
Journal:  Nat Genet       Date:  2007-08-05       Impact factor: 38.330

9.  B lymphocytes are essential for the initiation of T cell-mediated autoimmune diabetes: analysis of a new "speed congenic" stock of NOD.Ig mu null mice.

Authors:  D V Serreze; H D Chapman; D S Varnum; M S Hanson; P C Reifsnyder; S D Richard; S A Fleming; E H Leiter; L D Shultz
Journal:  J Exp Med       Date:  1996-11-01       Impact factor: 14.307

10.  CD8 T cell clones from young nonobese diabetic (NOD) islets can transfer rapid onset of diabetes in NOD mice in the absence of CD4 cells.

Authors:  F S Wong; I Visintin; L Wen; R A Flavell; C A Janeway
Journal:  J Exp Med       Date:  1996-01-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.